Article
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
31 Jan 2022
Abstract excerpt
Abstract The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1,2 that contribute to viral escape from antibody neutralization 3–6 and reduce vaccine protection from infection 7,8 . The extent to which other components of the adaptive response such as T cells may still target Omicron and contribute to protection from severe outcomes is unknown. Here we assessed the ability of T cells to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
